Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Innovation Pharmaceuticals IPIX
(Total Views: 430)
Posted On: 02/05/2021 4:54:50 PM
Post# of 72446
Avatar
Posted By: Drano
Washington Post editorial: We need therapeutic drugs. They specifically mention how monoclonal antibodies have been disappointing. Here is part of the article:

Quote:
Finally, and most importantly, we need greater focus on developing scalable treatments to prevent severe covid-19, shorten the duration of the disease and reduce deaths. At every turn, we have underestimated this virus. The current vaccines are effective — for now. But we should not assume that will remain the case as the virus mutates.

Plus, having vaccines is not a silver bullet, as we’ve already seen. It will take months to vaccinate every adult in the United States — much less globally — who wants to be vaccinated, and we must expect significant pockets of people to go unvaccinated and remain susceptible to serious infection. Trials for children — who can become seriously ill with covid-19, although it’s rare — have also not been completed. And if an updated vaccine booster becomes necessary to tackle these new variants, it will take yet more time for it to reach people.



https://www.washingtonpost.com/opinions/2021/...aC06A0nasw













(4)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site